Skip to main content
Livermore
Livermore
ZHEN

Xponance, Inc.

SEC CIK
0001637541
Latest filing
Aug 10, 2026

ARWR holding history

Arrowhead Pharmaceuticals, Inc. in every 13F filed by Xponance, Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ARWR overviewAll 13F holders of ARWRFull Q2 2026 holdings

Shares (Q2 2026)
24,473
Value
$1.99M
% of portfolio
<0.1%
Quarters held
20
Since Q1 2021
Holdings of ARWR by Xponance, Inc., by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202624,473$1.99M<0.1%+5,162+26.7%AddedHolders
Q1 202619,311$1.21M<0.1%+8,877+85.1%AddedHolders
Q4 202510,434$692.7K<0.1%+935+9.8%AddedHolders
Q3 20259,499$327.6K<0.1%+9,499NewHolders
Q1 20250$00.0%−17,400−100.0%Sold outHolders
Q4 202417,400$327.1K<0.1%+744+4.5%AddedHolders
Q3 202416,656$322.6K<0.1%+191+1.2%AddedHolders
Q2 202416,465$427.9K<0.1%−825−4.8%ReducedHolders
Q1 202417,290$494.5K<0.1%+2,198+14.6%AddedHolders
Q4 202315,092$461.8K<0.1%−37−0.2%ReducedHolders
Q3 202315,129$406.5K<0.1%−226−1.5%ReducedHolders
Q2 202315,355$547.6K<0.1%−1,203−7.3%ReducedHolders
Q1 202316,558$420.6K<0.1%+263+1.6%AddedHolders
Q4 202216,295$660.9K<0.1%−13−0.1%ReducedHolders
Q3 202216,308$539.0K<0.1%+15+0.1%AddedHolders
Q2 202216,293$574.0K<0.1%+897+5.8%AddedHolders
Q1 202215,396$708.0K<0.1%+67+0.4%AddedHolders
Q4 202115,329$1.02M<0.1%−274−1.8%ReducedHolders
Q3 202115,603$974.0K<0.1%−643−4.0%ReducedHolders
Q2 202116,246$1.34M<0.1%+4,883+43.0%AddedHolders
Q1 202111,363$753.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.